MedTrace Logo

Spectroscopic Evaluation of Cervical Neoplasia

NCT00766701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1599

Last updated 2008-10-06

No results posted yet for this study

Summary

The overall objective of this study is to evaluate whether fluorescence and reflectance spectroscopy can improve the ability to detect the presence of premalignant lesions on the cervix.

The specific aims of the study are:

* To compare information obtained from fluorescence and reflectance spectroscopic measurements of the cervix with standard methods for detecting cervical pre-cancers.
* To validate previously developed algorithms for discriminating between normal and pre-cancerous tissue based on spectroscopic measurements.
* To evaluate the safety of spectroscopic measurement of cervical tissue.

Conditions

  • Cervical Neoplasia

Interventions

PROCEDURE

Procedure: Spectroscopy and Digital Imaging

Procedure: Spectroscopy and Digital Imaging

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Guided Therapeutics

    lead INDUSTRY

Principal Investigators

  • Lisa Flowers, MD · Emory University/Grady Hospital System

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00766701 on ClinicalTrials.gov